Hemo Technology: Net loss in the first half of 2025 was 12.5581 million yuan, a year-on-year decrease of 66.67%.

HaiMo Technology announcement, the operating income in the first half of 2025 was 197 million yuan, a year-on-year increase of 20.28%. The net loss attributable to shareholders of the listed company was 12.5581 million yuan, a year-on-year decrease of 66.67%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase share capital by converting reserves.